Back to top
more

Biotechnology Ultra Sector Pro Fund, Service: (MF: BIPSX)

(NASDAQ Mutual Funds) As of Apr 17, 2024 08:00 PM ET

$35.07 USD

-0.61 (-1.71%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

NA

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Mar 31, 2024

Total Return %* Percentile Rank Objective
YTD 7.56 62
3 months 7.56 62
6 months 41.34 1
1 Year 29.16 9
3 Year 5.80 41
5 Year 10.02 36
10 Year 8.69 73

* Annual for three years and beyond.

Zacks Premium Research for BIPSX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

NA
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 8.71
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 3/31/2024 3.19
% Turnover 3/31/2024 300.00

Risk

3 Year 5 Year 10 Year
Beta 1.35 1.15 1.38
Alpha -4.50 -3.33 -4.62
R Squared 0.48 0.44 0.45
Std. Dev. 34.23 31.95 31.12
Sharpe 0.26 0.41 3.00

Sector / Country Weightings

As of 3/31/2024 % of Portfolio
Health 60.95
Other 31.74
Services 6.12
Industrial Cyclical 0.93
Technology 0.26

Portfolio Holdings

Top Equity Holdings
(As of 1/31/2024)
% of Portfolio Value (Mil$)
TOTAL*REPURCHASE AGREEMEN 26.24 27.92
CYTOKINETICS INC 2.06 2.19
KARUNA THERAPEUTICS INC 1.37 1.46
SAREPTA THERAPEUTICS INC 1.23 1.31
TOTAL*MONEY MARKET 1.22 1.30
BIOHAVEN LTD 1.21 1.29
ARDELYX INC 1.20 1.28
ARROWHEAD PHARMACEUTICALS 1.17 1.25
MODERNA INC 1.14 1.21

Stock Holding % of Net Assets

As Of 1/31/2024
Total Issues 119
Avg. P/E 32.51
Avg. P/Book 5.31
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 15,612

Allocation

% of Portfolio
Large Growth 0.00
Large Value 0.00
Small Growth 61.29
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 4.30
Foreign Bond 0.00
High Yield Bond 0.00